© 2021 MJH Life Sciences and AJMC. All rights reserved.
© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
July 22nd 2021, 3:00pm
The manipulation of key enzymes through methods of gene therapy was shown to provide protection against vision loss from multiple retinal conditions.
July 19th 2021, 5:45pm
Bobeck Modjtahedi, MD, highlights some of the challenges of using telehealth to treat individuals with diabetic retinopathy.
July 15th 2021, 2:00pm
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
July 11th 2021, 12:40pm
The development of a successful gene therapy for RPE65-associated inherited retinal disease is a major breakthrough, but it also prompts difficult questions about which patients are good candidates for the therapy.
July 10th 2021, 5:30pm
Hormonal contraceptive use among women of childbearing age was associated with a more than 2-fold higher risk of developing glaucoma, although risk was still relatively low.
July 9th 2021, 2:00pm
June 30th 2021, 12:30pm
A new meta-analysis finds rigorous evidence lacking; however, existing data suggest preservative-free formulations of beta-blockers may work just as well as preserved beta-blockers in reducing intraocular pressure.
June 24th 2021, 1:30pm
June 18th 2021, 3:00pm
June 16th 2021, 4:15pm
Over 20 years, 1 in 4 patients with ocular hypertension suffered visual field loss from primary open-angle glaucoma, according to a new study.